How To Say Goodbye to Sickle Cell Disease Forever: The Power of PGD
June 23, 2020
How can Preimplantation Genetic Diagnosis (PGD or PIGD) help reduce the risk of Sickle Cell Disease? Couples in relationships where both are carriers of a genetic illness find themselves in a particularly challenging situation. However, the power of PGD can make a difference for you – read on to learn how.
Preimplantation Genetic Diagnosis (PGD) is a procedure to assist parents at risk of passing a genetic condition to their children.
It has existed for several years (since the ’90s), carried out in highly specialised centres by exceptionally well-trained staff.
So PGD reduces the risk of transmitting a particular genetic condition from parent to child.
Sickle Cell Disease (SCD) is one of many conditions where this power of PGD could make a difference for families.
In Sickle Cell Disease, individuals have inherited the ‘S’ sickle gene, which affects the protein haemoglobin.
The altered haemoglobin changes the shape of the red blood cell.
This leads to several problems within the body, affecting the supply of oxygen – learn more.
People who have inherited 2 copies of the S gene (SS) suffer from Sickle Cell Anaemia.
They experience painful bone crises and are more at risk of severe anaemia and problems like a stroke – read more.
Others who have inherited the S gene and another abnormal haemoglobin B-Thalassemia can also have quite severe disease (S-BThalassemia genotype).
In both these cases, each parent could potentially pass the abnormal gene to their child.
This is how these children develop severe conditions; that is, by inheritance.
In the group of all sickle cell diseases, these are the people who will most benefit from the power of PGD.
The process of PGD determines whether the chromosomes of the developing foetus or embryo have the gene in question.
This happens within the first few days of existence.
The embryo develops from both parents via IVF (In-vitro Fertilisation), a highly specialised and delicate process.
First, doctors stimulate a woman’s ovaries to produce eggs.
Next, semen from the partner is obtained, and the most viable sperm are selected.
These will be coupled with the eggs in a delicate procedure until fertilisation happens.
Fertilisation is when the sperm and egg combine to form the foetus or embryo.
Early in the development of the embryo, some tissue is taken for analysis of its chromosomes.
This determines if it carries the affected gene and happens between the third to the sixth day after fertilisation.
(The timing only depends on the process used to obtain the sample cells)
There are different methods that an embryologist could use to collect the tissue that has one advantage or the other.
The most commonly used method allows doctors to retrieve a single cell from the 3-day-old embryo.
Another method allows the specialist to get more specific cells, but the embryo is older, risking its survival.
In the case of analysis of the cells taken from the embryo, there are also a number of methods.
A popular one is PCR – Polymerase Chain Reaction, which helps to diagnose gene conditions like Sickle Cell Disease.
In PCR, the cell’s DNA is amplified or copied many times in order to help the analysis.
It is necessary to test the chromosomes in the couple (and sometimes other family members).
This helps determine if those chromosomes in the embryo have any sign of the abnormal gene.
And this is the power of PGD.
The analysis of the chromosome from the embryo is a still-evolving science.
There are some reasons why an embryo that appears healthy may still have an abnormal gene.
Sometimes, embryos possess more than one type of cell.
It is possible that when taking the sample cells to test, the sample may not be fully representative of the embryo.
There may be laboratory contamination, or the amplified cell contains part of the mother or father that could affect the result.
If the PGD screening results in an embryo that appears free of genetic abnormality, the next step is to plant it in the mother’s womb to develop until maturity.
For the reasons above, even after PGD, specialists will recommend prenatal screening using either Chorionic Villus Sampling (CVS) or Amniocentesis to check that the foetus is free of the gene.
This happens around the time from 10 weeks to 16 weeks of pregnancy.
If all appears well, then pregnancy continues till delivery.
1. It requires specialist involvement – usually fertility experts for IVF and embryologists to collect the cells for testing from the embryo (embryo biopsy).
2. It requires specialist IVF facilities and laboratories for effective testing.
3. It takes considerable time – before, during and after the procedure.
4. There is still no guarantee after analysis that all abnormal chromosomes are detected, and the selected embryo is free of the affected gene.
5. There is a possibility of damage to the embryo during the analysis.
6. There are risks around prenatal testing – CVS or Amniocentesis – womb infection or miscarriage may result.
7. There are challenges with the cost of the procedure in countries where people pay out of pocket.
Despite the pros when taking advantage of the power of PGD, a good idea of its safety is important.
This will depend on some elements:
Potential areas of concern for safety are:
The couple will need to understand that while Preimplantation Genetic Diagnosis can reduce the chance of having a child with the SS genotype, it is not 100% certain.
Utilising the power of PGD also applies to the S-Bthalassemia condition.
In a very good facility, and with skilled professionals, of course, the chances are better, and the safety profile of the procedure is better.
When accessible, it is an option that can reduce the distress of considering a therapeutic abortion at an advanced stage of pregnancy.
Preimplantation Genetic Diagnosis is a procedure that has shown success, but any couple wishing to undertake it should clearly understand its benefits and challenges – which is where Genetic Counselling comes in.
Would you like to know more about this topic? Send an e-mail here
Editing by AskAwayHealth Team
All AskAwayHealth articles are written by practising Medical Practitioners on a wide range of healthcare conditions to provide evidence-based guidance and to help promote quality healthcare.
The advice in our material is not meant to replace the management of your specific condition by a qualified healthcare practitioner.
To discuss your condition, please contact a health practitioner or reach us directly
Image Credits: Canva
Want to know how your comment data is processed? Learn more